Ovid Therapeutics Total Shareholders Equity 2011-2026 | OVID

Annual Total Shareholders Equity Ovid Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
131 M	68.2 M	87.8 M	132 M	180 M	43.6 M	70 M	38.8 M	83.4 M	49.3 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
180 M	38.8 M	88.4 M

Quarterly Total Shareholders Equity Ovid Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
44.7 M	55.8 M	59.3 M	68.2 M	76.3 M	88.9 M	78.3 M	87.8 M	101 M	111 M	121 M	132 M	142 M	152 M	165 M	180 M	197 M	207 M	221 M	43.6 M	43.6 M	43.6 M	43.6 M	70 M	70 M	70 M	70 M	38.8 M	38.8 M	38.8 M	38.8 M	83.4 M	83.4 M	83.4 M	83.4 M	49.3 M	49.3 M	49.3 M	49.3 M	68.1 M	-	-	-	4.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
221 M	4.74 M	85.4 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Amgen AMGN	8.66 B	$ 349.36	2.75 %	$ 188 B	USA
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	-70.8 M	$ 12.67	2.82 %	$ 3.97 B	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	189 M	$ 24.45	5.07 %	$ 3.11 B	USA
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Autolus Therapeutics plc AUTL	178 M	$ 1.47	8.17 %	$ 391 M	Britain
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	35.5 M	$ 3.83	1.86 %	$ 9.21 B	Australia
BioNTech SE BNTX	1.37 B	$ 91.3	1.87 %	$ 27.2 B	Germany
CymaBay Therapeutics CBAY	292 M	-	-	$ 3.45 B	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	19 M	$ 2.72	5.84 %	$ 17.1 M	USA
Burford Capital Limited BUR	1.7 B	$ 4.59	0.88 %	$ 742 M	Britain
Avid Bioservices CDMO	60.9 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	163 M	-	-	$ 1.41 B	USA
Cabaletta Bio CABA	112 M	$ 3.07	-	$ 308 M	USA
Can-Fite BioPharma Ltd. CANF	5.44 M	$ 3.08	1.65 %	$ 6.7 B	Israel
Checkpoint Therapeutics CKPT	-12.6 M	-	-	$ 169 M	USA
Cerus Corporation CERS	64.2 M	$ 1.93	4.89 %	$ 368 M	USA
Checkmate Pharmaceuticals CMPI	69.5 M	-	-	$ 231 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	112 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	-17.6 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	6.84 M	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	8.54 M	$ 2.82	2.55 %	$ 7.36 M	USA
Deciphera Pharmaceuticals DCPH	351 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	597 M	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Cyclerion Therapeutics CYCN	8.85 M	$ 3.47	-0.29 %	$ 8.74 M	USA